Results 31 to 40 of about 32,814 (296)
Frontiers in Veterinary Science, 2023 The aim of the present study was to evaluate cardiac indices using M-mode echocardiography after the administration of metoclopramide and ondansetron in donkeys.
Mohamed Marzok +14 more
doaj +1 more source
Metoclopramide in gastrooesophageal reflux [PDF]
Gut, 1973 In 30 patients with gastrooesophageal reflux, intravenous metoclopramide (Maxolon) has been shown to increase the gastrooesophageal sphincter pressure. The rise is dose-related until a maximum pressure, proportional to the resting sphincter tone, is reached. The effect is reversed by atropine.
C. Stanciu, John R Bennett
openaire +3 more sources
Metoclopramide-induced cardiac arrest
Clinics and Practice, 2011 The authors report a case of cardiac arrest in a patient receiving intravenous (IV) metoclopramide and review the pertinent literature. A 62-year-old morbidly obese female admitted for a gastric sleeve procedure, developed cardiac arrest within one ...
Martha M. Rumore +3 more
doaj +1 more source
Case report: metoclopramide induced acute dystonic reaction in adolescent CYP2D6 poor metabolizers
Frontiers in Pharmacology, 2023 Metoclopramide is indicated for the management of gastroesophageal reflux, gastric stasis, nausea, and vomiting. Metoclopramide-induced acute dystonic reactions (MIADRs), along with repetitive involuntary protrusion of the tongue, are well-known ...
Franz-Martin Fink +4 more
doaj +1 more source
Prevention of Post-cesarean Nausea and vomiting by Intramuscular Metoclopramide: A Randomized Clinical trial [PDF]
Journal of Midwifery & Reproductive Health, 2019 Background & aim: Nausea and vomiting are considered as the main post-cesarean complications in women undergoing cesarean section. Therefore, the present study aimed to examine the efficacy of intramuscular metoclopramide before cesarean section to ...
Jila Agah +3 more
doaj +1 more source
Clinical Pharmacology in Drug Development, EarlyView.Abstract Endogenous oxytocin plays an important role in lactation, but its effectiveness as an exogenous galactagogue has been modest due to dose‐limiting side effects related to off‐target effects at the vasopressin V2 receptor. Merotocin (FE 202767) is a short‐acting peptidic oxytocin receptor agonist with the potential to aid mothers experiencing ...
Yu Bagger +4 more
wiley +1 more source
Interventions for treating hyperemesis gravidarum. [PDF]
, 2016 BACKGROUND: Hyperemesis gravidarum is a severe form of nausea and vomiting in pregnancy affecting 0.3% to 1.0% of pregnancies, and is one of the most common indications for hospitalization during pregnancy.
Abas +96 more
core +2 more sources
The impact and management of hyperemesis gravidarum: Current and future perspectives
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting in pregnancy affecting around 1%–3% of pregnancies worldwide and is the most common reason for hospital admission in early pregnancy. HG can have lasting consequences for both pregnant individuals and their offspring.
L. M. van der Minnen +4 more
wiley +1 more source
Effects of Single-Dose Prucalopride on Intestinal Hypomotility in Horses: Preliminary Observations [PDF]
, 2017 Abnormalities of gastrointestinal motility are often a challenge in horses; however, the use of prokinetic drugs in such conditions must be firmly established yet.
Bassotti, G. +7 more
core +2 more sources
Cancer in pregnancy: FIGO Best practice advice and narrative review
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Cancer during pregnancy is relatively rare. The incidence is underestimated due to the lack of international registries covering both high‐income and low‐ and middle‐income countries, and is expected to rise with increasing maternal age and increasing global adoption of cell‐free DNA testing for aneuploidy.
Surabhi Nanda +29 more
wiley +1 more source